Methyl 4-(Butyrylamino)-3-Methyl-5-Nitrobenzoate CAS 152628-01-8 Pite> 99.0% (HPLC) Telmisartan Entèmedyè Faktori
Ruifu Chimik Pwovizyon pou Telmisartan Entèmedyè ak Pite segondè
Telmisartan CAS 144701-48-4
Methyl 2-(p-Tolyl)benzoate CAS 114772-34-8
2-(p-Tolyl) asid benzoik CAS 7148-03-0
Telmisartan Benzimidazole Asid CAS 152628-03-0
Telmisartan Methyl Ester CAS 528560-93-2
Methyl 2-[4-(Bromethyl)phenyl]benzoate CAS 114772-38-2
Methyl 4-(Butyrylamino)-3-Methyl-5-Nitrobenzoate CAS 152628-01-8
2-n-Propyl-4-Methyl-6-(1-Methylbenzimidazole-2-yl)benzimidazole CAS 152628-02-9
Non Chimik | Methyl 4-(Butyrylamino)-3-Methyl-5-Nitrobenzoate |
Sinonim | Telmisartan enpurte 31;3-Methyl-4-Butyrylamido-5-Nitro Benzoic Asid Methyl Ester;4-Butyrylamino-3-methyl-5-nitrobenzoic Asid Methyl Ester |
Nimewo CAS | 152628-01-8 |
Nimewo CAT | RF-PI1881 |
Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
Fòmil molekilè | C13H16N2O5 |
Pwa molekilè | 280.28 |
Pwen k ap fonn | 151.0 ~ 153.0 ℃ |
Dansite | 1.265 |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Poud blan |
Pite / Metòd analiz | >99.0% (HPLC) |
Pèt sou siye | <1.00% |
Rezid sou ignisyon | <0.50% |
Enpurte total | <1.00% |
Metal lou (tankou Pb) | <20ppm |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan Telmisartan (CAS: 144701-48-4) |
Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite
Methyl 4-(Butyrylamino)-3-Methyl-5-Nitrobenzoate (CAS: 152628-01-8) se yon itil entèmedyè sentetik nan pwodiksyon an nan Telmisartan (CAS: 144701-48-4), yon dwòg antihypertansive.Methyl 4-(Butyrylamino)-3-Methyl-5-Nitrobenzoate se yon pati nan yon pwosesis ki pi efikas nan sentèz Telmisartan an tèm de enpurte, sede, pri, ak pwodiksyon gwo echèl.Telmisartan se yon bloke reseptè anjyotansin II (ARB) ki endike pou: Tretman tansyon wo, pou bese tansyon.Bese tansyon diminye risk pou evènman kadyovaskilè fatal ak ki pa fatal, sitou kou ak enfaktis myokad.Rediksyon risk kadyovaskilè (CV) nan pasyan ki pa kapab pran inibitè ACE.